Advanced Medical Solutions Group (LON:AMS) Hits New 52-Week Low - Should You Sell?

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 177 ($2.35) and last traded at GBX 182.80 ($2.43), with a volume of 716075 shares. The stock had previously closed at GBX 182.60 ($2.43).

Wall Street Analyst Weigh In

Separately, Berenberg Bank reaffirmed a "buy" rating and set a GBX 300 ($3.99) price target on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 19th.

Advanced Medical Solutions Group Stock Performance

The firm has a market cap of £381.33 million, a price-to-earnings ratio of 34.22, a P/E/G ratio of 5.00 and a beta of 0.74. The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58. The firm has a fifty day simple moving average of GBX 203.46 and a two-hundred day simple moving average of GBX 206.67.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last released its earnings results on Thursday, March 20th. The company reported GBX 10.65 ($0.14) EPS for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. On average, analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current year.

Advanced Medical Solutions Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, June 20th. Stockholders of record on Thursday, May 29th will be paid a dividend of GBX 1.83 ($0.02) per share. This is an increase from Advanced Medical Solutions Group's previous dividend of $0.77. This represents a dividend yield of 0.89%. The ex-dividend date of this dividend is Thursday, May 29th. Advanced Medical Solutions Group's payout ratio is presently 38.76%.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.